| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNICAMPANIASUN0132680 |
|
|
Autore |
Sivolella, Davide |
|
|
Titolo |
To Orbit and Back Again : How the Space Shuttle Flew in Space / Davide Sivolella |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
xxii, 502 p., : ill. ; 24 cm |
|
|
|
|
|
|
|
Edizione |
[New York : Springer] |
|
|
|
|
|
Descrizione fisica |
|
Pubblicazione in formato elettronico |
|
|
|
|
|
|
Soggetti |
|
85-XX - Astronomy and Astrophysics [MSC 2020] |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9910317569403321 |
|
|
Autore |
Ali Demir Sezer |
|
|
Titolo |
Recent Advances in Novel Drug Carrier Systems / / edited by Ali Demir Sezer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
IntechOpen, 2012 |
|
Rijeka, Croatia : , : IntechOpen, , 2012 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (x, 514 pages) : illustrations |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Sommario/riassunto |
|
This contribution book collects reviews and original articles from eminent experts working in the interdisciplinary arena of novel drug delivery systems and their uses. From their direct and recent experience, the readers can achieve a wide vision on the new and |
|
|
|
|
|
|
|
|
|
|
ongoing potentialities of different drug delivery systems. Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. On the other hand, this reference discusses advances in the design, optimization, and adaptation of gene delivery systems for the treatment of cancer, cardiovascular, pulmonary, genetic, and infectious diseases, and considers assessment and review procedures involved in the development of gene-based pharmaceuticals. |
|
|
|
|
|
| |